Michael J. Brooks, President at Edesa Biotech, Inc. (EDSA), bought 2,000 shares at $1.57 ($3K) on 2026-02-26, disclosed to the SEC on 2026-03-11.
Open-market purchase of $3k EDSA by President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| EDSA | BUY | 2022-05-26 | $6K | — | Filing → |
| EDSA | BUY | 2022-03-15 | $3K | — | Filing → |
| EDSA | BUY | 2022-03-11 | $3K | — | Filing → |